Epithin, a target of transforming growth factor-β signaling, mediates epithelial-mesenchymal transition

Hyo Seon Lee, Chungho Kim, Sang Bum Kim, Moon Gyo Kim, Dongeun Park

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The epithelial-derived type II transmembrane serine protease epithin has been shown to be upregulated in a variety of cancer cell lines and tumor tissues, and its upregulation correlates well with tumor progression in many cases. However, little is known regarding the regulation of its expression and the mechanism of its roles in tumor progression. Here, we show that transforming growth factor-β (TGF-β), a potent inducer of epithelial-mesenchymal transition (EMT) in tumor progression, upregulates epithin, and that epithin plays a critical role in TGF-β-induced EMT. Forced overexpression of epithin induced EMT to exhibit characteristic morphological changes, alternations in EMT-related proteins and enhanced cell motility. Conversely, shRNA-mediated knockdown of endogenous epithin inhibited TGF-β-induced expression of mesenchymal markers and morphological changes. Furthermore, TGF-β-induced cell migration and invasion were significantly impaired by epithin knockdown. In addition, we demonstrate that TGF-β upregulates epithin transcriptionally via the Smad2/Smad4-mediated pathway. These results suggest that epithin is a key mediator of TGF-β-induced EMT in tumor progression.

Original languageEnglish
Pages (from-to)553-559
Number of pages7
JournalBiochemical and Biophysical Research Communications
Volume395
Issue number4
DOIs
Publication statusPublished - 2010 May 14
Externally publishedYes

Fingerprint

Epithelial-Mesenchymal Transition
Transforming Growth Factors
Tumors
Up-Regulation
Neoplasms
Cell Movement
Serine Proteases
Tumor Cell Line
Small Interfering RNA
Cells
Tissue
Proteins

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Molecular Biology

Cite this

Epithin, a target of transforming growth factor-β signaling, mediates epithelial-mesenchymal transition. / Lee, Hyo Seon; Kim, Chungho; Kim, Sang Bum; Kim, Moon Gyo; Park, Dongeun.

In: Biochemical and Biophysical Research Communications, Vol. 395, No. 4, 14.05.2010, p. 553-559.

Research output: Contribution to journalArticle

@article{a9a61ae4cef04a2cbd276fe795914c89,
title = "Epithin, a target of transforming growth factor-β signaling, mediates epithelial-mesenchymal transition",
abstract = "The epithelial-derived type II transmembrane serine protease epithin has been shown to be upregulated in a variety of cancer cell lines and tumor tissues, and its upregulation correlates well with tumor progression in many cases. However, little is known regarding the regulation of its expression and the mechanism of its roles in tumor progression. Here, we show that transforming growth factor-β (TGF-β), a potent inducer of epithelial-mesenchymal transition (EMT) in tumor progression, upregulates epithin, and that epithin plays a critical role in TGF-β-induced EMT. Forced overexpression of epithin induced EMT to exhibit characteristic morphological changes, alternations in EMT-related proteins and enhanced cell motility. Conversely, shRNA-mediated knockdown of endogenous epithin inhibited TGF-β-induced expression of mesenchymal markers and morphological changes. Furthermore, TGF-β-induced cell migration and invasion were significantly impaired by epithin knockdown. In addition, we demonstrate that TGF-β upregulates epithin transcriptionally via the Smad2/Smad4-mediated pathway. These results suggest that epithin is a key mediator of TGF-β-induced EMT in tumor progression.",
keywords = "Epithelial-mesenchymal transition, Epithin, TGF-β",
author = "Lee, {Hyo Seon} and Chungho Kim and Kim, {Sang Bum} and Kim, {Moon Gyo} and Dongeun Park",
year = "2010",
month = "5",
day = "14",
doi = "10.1016/j.bbrc.2010.04.065",
language = "English",
volume = "395",
pages = "553--559",
journal = "The BMJ",
issn = "0730-6512",
publisher = "Kluwer Academic Publishers",
number = "4",

}

TY - JOUR

T1 - Epithin, a target of transforming growth factor-β signaling, mediates epithelial-mesenchymal transition

AU - Lee, Hyo Seon

AU - Kim, Chungho

AU - Kim, Sang Bum

AU - Kim, Moon Gyo

AU - Park, Dongeun

PY - 2010/5/14

Y1 - 2010/5/14

N2 - The epithelial-derived type II transmembrane serine protease epithin has been shown to be upregulated in a variety of cancer cell lines and tumor tissues, and its upregulation correlates well with tumor progression in many cases. However, little is known regarding the regulation of its expression and the mechanism of its roles in tumor progression. Here, we show that transforming growth factor-β (TGF-β), a potent inducer of epithelial-mesenchymal transition (EMT) in tumor progression, upregulates epithin, and that epithin plays a critical role in TGF-β-induced EMT. Forced overexpression of epithin induced EMT to exhibit characteristic morphological changes, alternations in EMT-related proteins and enhanced cell motility. Conversely, shRNA-mediated knockdown of endogenous epithin inhibited TGF-β-induced expression of mesenchymal markers and morphological changes. Furthermore, TGF-β-induced cell migration and invasion were significantly impaired by epithin knockdown. In addition, we demonstrate that TGF-β upregulates epithin transcriptionally via the Smad2/Smad4-mediated pathway. These results suggest that epithin is a key mediator of TGF-β-induced EMT in tumor progression.

AB - The epithelial-derived type II transmembrane serine protease epithin has been shown to be upregulated in a variety of cancer cell lines and tumor tissues, and its upregulation correlates well with tumor progression in many cases. However, little is known regarding the regulation of its expression and the mechanism of its roles in tumor progression. Here, we show that transforming growth factor-β (TGF-β), a potent inducer of epithelial-mesenchymal transition (EMT) in tumor progression, upregulates epithin, and that epithin plays a critical role in TGF-β-induced EMT. Forced overexpression of epithin induced EMT to exhibit characteristic morphological changes, alternations in EMT-related proteins and enhanced cell motility. Conversely, shRNA-mediated knockdown of endogenous epithin inhibited TGF-β-induced expression of mesenchymal markers and morphological changes. Furthermore, TGF-β-induced cell migration and invasion were significantly impaired by epithin knockdown. In addition, we demonstrate that TGF-β upregulates epithin transcriptionally via the Smad2/Smad4-mediated pathway. These results suggest that epithin is a key mediator of TGF-β-induced EMT in tumor progression.

KW - Epithelial-mesenchymal transition

KW - Epithin

KW - TGF-β

UR - http://www.scopus.com/inward/record.url?scp=77953124691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953124691&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2010.04.065

DO - 10.1016/j.bbrc.2010.04.065

M3 - Article

C2 - 20398629

AN - SCOPUS:77953124691

VL - 395

SP - 553

EP - 559

JO - The BMJ

JF - The BMJ

SN - 0730-6512

IS - 4

ER -